Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists - LY53857, sergolexole, and LY237733 - McBride, P A; Mann, J J; Nimchinski, E; Cohen, M L (Life Sci, 1990)